Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T‐cell lymphomas-Reference-Cited by-同舟云学术

Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T‐cell lymphomas

Published:2019-05-30 Issue:3 Volume:37 Page:270-276
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Zhang Xuhan¹²,Liu Lu¹,Zhou Shiyong¹,Zhao Kuo¹,Song Zheng¹,Hu Ge¹,Zhang Tingting¹,Li Yang¹,Qiu Lihua¹,Li Lanfang¹,Qian Zhengzi¹,Meng Bin³,Pan Yi³,Ren Xiubao⁴,Wang Xianhuo¹^ORCID,Zhang Huilai¹,Fu Kai¹⁵

Affiliation:

1. Department of LymphomaTianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino‐US Center for Lymphoma and Leukemia Research Tianjin China

2. Department of Radiotherapy OncologyCangzhou Central Hospital Hebei China

3. Department of PathologyTianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino‐US Center for Lymphoma and Leukemia Research Tianjin China

4. Department of Immunology/BiotherapyTianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino‐US Center for Lymphoma and Leukemia Research Tianjin China

5. Department of Pathology and MicrobiologyUniversity of Nebraska Medical Center Omaha NE USA

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2636

Reference33 articles.

1. International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

2. Guidelines for the management of mature T‐cell and NK‐cell neoplasms (excluding cutaneous T‐cell lymphoma)